Logo image of CHS

Chicos FAS Inc (CHS) Stock Fundamental Analysis

NYSE:CHS - US1686151028 - Common Stock

7.59 USD
-0.01 (-0.13%)
Last: 1/4/2024, 8:04:00 PM
7.591 USD
+0 (+0.01%)
After Hours: 1/4/2024, 8:04:00 PM
Fundamental Rating

5

Overall CHS gets a fundamental rating of 5 out of 10. We evaluated CHS against 123 industry peers in the Specialty Retail industry. CHS has an average financial health and profitability rating. CHS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHS was profitable.
CHS had a positive operating cash flow in the past year.
In multiple years CHS reported negative net income over the last 5 years.
CHS had a positive operating cash flow in 4 of the past 5 years.
CHS Yearly Net Income VS EBIT VS OCF VS FCFCHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
Looking at the Return On Equity, with a value of 26.40%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
The Return On Invested Capital of CHS (12.31%) is better than 77.52% of its industry peers.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
CHS Yearly ROA, ROE, ROICCHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

With a decent Profit Margin value of 5.29%, CHS is doing good in the industry, outperforming 72.87% of the companies in the same industry.
In the last couple of years the Profit Margin of CHS has grown nicely.
With a decent Operating Margin value of 6.16%, CHS is doing good in the industry, outperforming 68.22% of the companies in the same industry.
In the last couple of years the Operating Margin of CHS has grown nicely.
CHS has a Gross Margin of 38.94%. This is comparable to the rest of the industry: CHS outperforms 59.69% of its industry peers.
CHS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
CHS Yearly Profit, Operating, Gross MarginsCHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

6

2. Health

2.1 Basic Checks

CHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CHS has more shares outstanding
CHS has less shares outstanding than it did 5 years ago.
CHS has a better debt/assets ratio than last year.
CHS Yearly Shares OutstandingCHS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
CHS Yearly Total Debt VS Total AssetsCHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
CHS has a Altman-Z score of 3.22. This is in the better half of the industry: CHS outperforms 70.54% of its industry peers.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
CHS has a better Debt to FCF ratio (0.42) than 82.17% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, CHS is in the better half of the industry, outperforming 75.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%
CHS Yearly LT Debt VS Equity VS FCFCHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.20, CHS is doing worse than 72.09% of the companies in the same industry.
CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
CHS has a Quick ratio of 0.42. This is in the lower half of the industry: CHS underperforms 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42
CHS Yearly Current Assets VS Current LiabilitesCHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

CHS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
The Earnings Per Share has been growing slightly by 4.10% on average over the past years.
Looking at the last year, CHS shows a decrease in Revenue. The Revenue has decreased by -0.24% in the last year.
CHS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.26% yearly.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%

3.2 Future

CHS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.47% yearly.
CHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHS Yearly Revenue VS EstimatesCHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CHS Yearly EPS VS EstimatesCHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

CHS is valuated reasonably with a Price/Earnings ratio of 9.86.
CHS's Price/Earnings ratio is a bit cheaper when compared to the industry. CHS is cheaper than 79.07% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHS to the average of the S&P500 Index (27.03), we can say CHS is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.29, the valuation of CHS can be described as very reasonable.
74.42% of the companies in the same industry are more expensive than CHS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.54, CHS is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
CHS Price Earnings VS Forward Price EarningsCHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CHS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHS is cheaper than 85.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72
CHS Per share dataCHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of CHS may justify a higher PE ratio.
CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Chicos FAS Inc

NYSE:CHS (1/4/2024, 8:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30 2023-11-30/bmo
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S 0.44
P/FCF 16.37
P/OCF 8.25
P/B 2.22
P/tB 2.34
EV/EBITDA 4.72
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE 15.79%
ROIC 12.31%
ROICexc 14.55%
ROICexgc 15.01%
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM 2.71%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Debt/EBITDA 0.14
Cap/Depr 134.65%
Cap/Sales 2.67%
Interest Coverage 35.98
Cash Conversion 66.14%
Profit Quality 51.32%
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z 3.22
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%